Bassano Corp.: Stitching Up the Wounds of Poor Project Management Custom Case Solution & Analysis

1. Evidence Brief: Case Extraction

Financial Metrics

Project Budget Variance: The primary project exceeded the initial capital allocation by 28 percent.
Revenue Impact: Delayed market entry resulted in an estimated loss of 4.2 million dollars in first-year sales.
Operating Margins: Production inefficiencies and rework costs reduced divisional margins from 18 percent to 11.5 percent over the fiscal year.
Inventory Costs: Excess raw materials for the stalled project increased carrying costs by 12 percent compared to the previous period.

Operational Facts

Project Duration: The development cycle lasted 22 months against an original schedule of 14 months.
Quality Control: Post-launch defect rates reached 7 percent, significantly higher than the 2 percent industry standard for medical garments.
Headcount: The project team consisted of 15 full-time employees, but lacked a dedicated project manager for the first 8 months.
Geography: Manufacturing occurs in Northern Italy with distribution centers across Western Europe and North America.

Stakeholder Positions

The CEO: Views formal project management as unnecessary bureaucracy that slows down entrepreneurial speed.
The Project Manager: Reports a lack of authority over cross-functional team members from R and D and Marketing.
Head of Operations: Expresses frustration with shifting requirements that disrupt manufacturing schedules.
External Vendors: Report inconsistent communication and delayed approvals on technical specifications.

Information Gaps

Specific Competitor Data: The case does not provide precise market share figures for the three main rivals.
Employee Turnover: Data on staff retention within the project team during the 22-month cycle is absent.
Customer Feedback: Direct quantitative data on customer satisfaction regarding the delayed product is missing.

2. Strategic Analysis: Professionalizing Execution

Core Strategic Question

How can Bassano Corp. transition from an informal, founder-led execution style to a disciplined project management structure without sacrificing its speed to market?

Structural Analysis

Applying the Organizational Life Cycle framework reveals that Bassano Corp. has outgrown its entrepreneurial stage. The current friction is a direct result of management systems failing to scale alongside product complexity. The lack of centralized governance creates a vacuum where departmental priorities override project goals. The Value Chain analysis indicates that the primary bottleneck exists at the intersection of Design and Manufacturing, where the absence of a formal hand-off process leads to expensive late-stage revisions.

Strategic Options

Option 1: Establish a Centralized Project Management Office (PMO). This involves hiring a Director of PMO with the authority to standardize tools and reporting across all departments. This provides high visibility and accountability but risks cultural pushback from the CEO and long-term staff.

Option 2: Implement a Hybrid Agile-Stage-Gate Framework. This maintains the creative flexibility of the design phase while enforcing rigid milestones for manufacturing and clinical testing. It requires significant training but balances speed with quality control.

Option 3: Outsource Project Oversight to a Third-Party Firm. This provides immediate expertise without increasing permanent headcount. However, it fails to build internal capabilities and may be viewed as an external intrusion by the current team.

Preliminary Recommendation

Bassano Corp. should pursue Option 1. The 28 percent budget overrun and 7 percent defect rate indicate a terminal failure of informal systems. A centralized PMO is the only mechanism that provides the structural discipline required to manage the increasing complexity of medical device regulations and global supply chains. The cost of the PMO will be offset by the reduction in rework and the acceleration of revenue cycles.

3. Implementation Roadmap: The 90-Day Plan

Critical Path

Days 1-15: Conduct a post-mortem on the failed project to identify specific process breakdown points.
Days 16-45: Design a standardized project charter template and select a unified digital tracking tool.
Days 46-75: Appoint a dedicated Project Lead for the next product cycle with explicit authority over cross-functional resources.
Days 76-90: Launch a pilot project using the new governance structure and clear success metrics.

Key Constraints

Cultural Resistance: The CEO remains the primary obstacle to adoption. Success depends on framing PMO metrics in terms of financial predictability rather than administrative compliance.
Skill Deficit: The current staff lacks formal training in risk assessment and critical path methodology.
Siloed Incentives: Department heads are currently rewarded for local optimization rather than project success.

Risk-Adjusted Implementation Strategy

The implementation will follow a phased rollout to minimize disruption. Instead of a company-wide overhaul, the new PMO standards will apply only to high-capital projects initially. A contingency of 15 percent in the timeline accounts for the learning curve associated with new software and reporting requirements. If the pilot project does not show a 10 percent improvement in milestone adherence by month six, the governance model will be simplified to focus exclusively on the Design-to-Manufacturing hand-off.

4. Executive Review and BLUF

BLUF

Bassano Corp. is experiencing a crisis of scale. The 28 percent budget overrun and significant market entry delay are symptoms of an entrepreneurial culture that has become an operational liability. To remain competitive, the company must immediately centralize project governance through a formal PMO. The primary risk is not the cost of implementation but the continued resistance of leadership to structured processes. Without this shift, Bassano Corp. will continue to see margin erosion and quality failures that threaten its reputation in the medical sector. The recommendation is to authorize a PMO pilot for the next product cycle with a focus on financial accountability and cross-functional visibility.

Dangerous Assumption

The analysis assumes that the CEO will cede enough authority to a Project Manager to make the PMO effective. If the CEO continues to bypass formal channels or override project decisions, the new structure will only add cost without improving outcomes.

Unaddressed Risks

Talent Flight: High-performing creative staff may perceive new structures as restrictive and seek opportunities at smaller, less regulated firms. Probability: Moderate. Consequence: High.
Regulatory Shift: While the plan focuses on internal efficiency, a sudden change in medical garment regulations could render the new standardized processes obsolete before they are fully embedded. Probability: Low. Consequence: Moderate.

Unconsidered Alternative

The team did not fully explore a divestiture or licensing model. Instead of fixing the broken manufacturing and project management internal systems, Bassano Corp. could focus exclusively on design and brand management, outsourcing the high-risk execution and production phases to specialized contract manufacturers with established PMO structures.